Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated:  11/22/2016
Hunterdon Regional Cancer Center
mi
from
Flemington, NJ
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated: 11/22/2016
Hunterdon Regional Cancer Center
mi
from
Flemington, NJ
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated:  11/22/2016
Kimball Medical Center
mi
from
Lakewood, NJ
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated: 11/22/2016
Kimball Medical Center
mi
from
Lakewood, NJ
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated:  11/22/2016
Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County
mi
from
Mount Holly, NJ
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated: 11/22/2016
Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County
mi
from
Mount Holly, NJ
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated:  11/22/2016
Riverview Medical Center
mi
from
Red Bank, NJ
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated: 11/22/2016
Riverview Medical Center
mi
from
Red Bank, NJ
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated:  11/22/2016
Community Medical Center, Inc
mi
from
Toms River, NJ
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated: 11/22/2016
Community Medical Center, Inc
mi
from
Toms River, NJ
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated:  11/22/2016
St. Francis Medical Center
mi
from
Trenton, NJ
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated: 11/22/2016
St. Francis Medical Center
mi
from
Trenton, NJ
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated:  11/22/2016
Bon Secours-Holy Family Health System
mi
from
Altoona, PA
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated: 11/22/2016
Bon Secours-Holy Family Health System
mi
from
Altoona, PA
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated:  11/22/2016
Delaware County Memorial Hospital
mi
from
Drexel Hill, PA
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated: 11/22/2016
Delaware County Memorial Hospital
mi
from
Drexel Hill, PA
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated:  11/22/2016
Pinnacle Health Hospitals
mi
from
Harrisburg, PA
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated: 11/22/2016
Pinnacle Health Hospitals
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated:  11/22/2016
Conemaugh Memorial Hospital
mi
from
Johnstown, PA
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated: 11/22/2016
Conemaugh Memorial Hospital
mi
from
Johnstown, PA
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated:  11/22/2016
Saint Mary Regional Center
mi
from
Langhorne, PA
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated: 11/22/2016
Saint Mary Regional Center
mi
from
Langhorne, PA
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated:  11/22/2016
North Penn Hospital
mi
from
Lansdale, PA
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated: 11/22/2016
North Penn Hospital
mi
from
Lansdale, PA
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated:  11/22/2016
Paoli Memorial Hospital
mi
from
Paoli, PA
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated: 11/22/2016
Paoli Memorial Hospital
mi
from
Paoli, PA
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated:  11/22/2016
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated: 11/22/2016
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated:  11/22/2016
Pottstown Memorial Regional Cancer Center
mi
from
Pottstown, PA
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated: 11/22/2016
Pottstown Memorial Regional Cancer Center
mi
from
Pottstown, PA
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated:  11/22/2016
Reading Hospital and Medical Center
mi
from
Reading, PA
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated: 11/22/2016
Reading Hospital and Medical Center
mi
from
Reading, PA
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated:  11/22/2016
Southern Chester County Medical Center
mi
from
West Grove, PA
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer
Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer
Status: Enrolling
Updated: 11/22/2016
Southern Chester County Medical Center
mi
from
West Grove, PA
Click here to add this to my saved trials
Phase 1 Study OF CDC-501 in Patients With Solid Tumors
A Single-Center, Open-Label, Between-Patient, Dose-Escalation Phase 1 Study of CDC-501 In Patients With Solid Tumors
Status: Enrolling
Updated:  11/22/2016
Wake Forest University
mi
from
Winston-Salem, NC
Phase 1 Study OF CDC-501 in Patients With Solid Tumors
A Single-Center, Open-Label, Between-Patient, Dose-Escalation Phase 1 Study of CDC-501 In Patients With Solid Tumors
Status: Enrolling
Updated: 11/22/2016
Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer
Imaging Prostatic Lipids to Distinguish Aggressive Prostate Cancer
Status: Enrolling
Updated:  11/28/2016
Portland VA Medical Center
mi
from
Portland, OR
Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer
Imaging Prostatic Lipids to Distinguish Aggressive Prostate Cancer
Status: Enrolling
Updated: 11/28/2016
Portland VA Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer
Imaging Prostatic Lipids to Distinguish Aggressive Prostate Cancer
Status: Enrolling
Updated:  11/28/2016
Oregon Health & Science University Advanced Imaging Research Center
mi
from
Portland, OR
Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer
Imaging Prostatic Lipids to Distinguish Aggressive Prostate Cancer
Status: Enrolling
Updated: 11/28/2016
Oregon Health & Science University Advanced Imaging Research Center
mi
from
Portland, OR
Click here to add this to my saved trials
Pancreatic Resection, Malnutrition and Readmission
Pancreatic Resection, Malnutrition, and Readmission: Assessment and Prevention
Status: Enrolling
Updated:  11/28/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Pancreatic Resection, Malnutrition and Readmission
Pancreatic Resection, Malnutrition, and Readmission: Assessment and Prevention
Status: Enrolling
Updated: 11/28/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV
Status: Enrolling
Updated:  11/29/2016
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
mi
from
Philadelphia, PA
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV
Status: Enrolling
Updated: 11/29/2016
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV
Status: Enrolling
Updated:  11/29/2016
Fox Chase Cancer Center - Philadelphia
mi
from
Philadelphia, PA
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV
Status: Enrolling
Updated: 11/29/2016
Fox Chase Cancer Center - Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies
Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/29/2016
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies
Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/29/2016
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Comparative Effectiveness of CTC & OC
Comparative Effectiveness of Virtual and Optical Colonoscopy for Colorectal (CRC) Surveillance
Status: Enrolling
Updated:  11/29/2016
University of Chicago
mi
from
Chicago, IL
Comparative Effectiveness of CTC & OC
Comparative Effectiveness of Virtual and Optical Colonoscopy for Colorectal (CRC) Surveillance
Status: Enrolling
Updated: 11/29/2016
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Comparative Effectiveness of CTC & OC
Comparative Effectiveness of Virtual and Optical Colonoscopy for Colorectal (CRC) Surveillance
Status: Enrolling
Updated:  11/29/2016
The Mayo Clinic
mi
from
Rochester, MN
Comparative Effectiveness of CTC & OC
Comparative Effectiveness of Virtual and Optical Colonoscopy for Colorectal (CRC) Surveillance
Status: Enrolling
Updated: 11/29/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Comparative Effectiveness of CTC & OC
Comparative Effectiveness of Virtual and Optical Colonoscopy for Colorectal (CRC) Surveillance
Status: Enrolling
Updated:  11/29/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Comparative Effectiveness of CTC & OC
Comparative Effectiveness of Virtual and Optical Colonoscopy for Colorectal (CRC) Surveillance
Status: Enrolling
Updated: 11/29/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Comparative Effectiveness of CTC & OC
Comparative Effectiveness of Virtual and Optical Colonoscopy for Colorectal (CRC) Surveillance
Status: Enrolling
Updated:  11/29/2016
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Comparative Effectiveness of CTC & OC
Comparative Effectiveness of Virtual and Optical Colonoscopy for Colorectal (CRC) Surveillance
Status: Enrolling
Updated: 11/29/2016
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Comparative Effectiveness of CTC & OC
Comparative Effectiveness of Virtual and Optical Colonoscopy for Colorectal (CRC) Surveillance
Status: Enrolling
Updated:  11/29/2016
University of Wisconsin-Madison
mi
from
Madison, WI
Comparative Effectiveness of CTC & OC
Comparative Effectiveness of Virtual and Optical Colonoscopy for Colorectal (CRC) Surveillance
Status: Enrolling
Updated: 11/29/2016
University of Wisconsin-Madison
mi
from
Madison, WI
Click here to add this to my saved trials
A Study of Neoadjuvant Photodynamic Immunomodulation for Colon Cancer
A Phase I/II Study of Neoadjuvant Photodynamic Immunomodulation for Colon Cancer
Status: Enrolling
Updated:  11/30/2016
The University of California Irvine
mi
from
Orange, CA
A Study of Neoadjuvant Photodynamic Immunomodulation for Colon Cancer
A Phase I/II Study of Neoadjuvant Photodynamic Immunomodulation for Colon Cancer
Status: Enrolling
Updated: 11/30/2016
The University of California Irvine
mi
from
Orange, CA
Click here to add this to my saved trials
A Study of Neoadjuvant Photodynamic Immunomodulation for Colon Cancer
A Phase I/II Study of Neoadjuvant Photodynamic Immunomodulation for Colon Cancer
Status: Enrolling
Updated:  11/30/2016
Mounst Sinai School of Medicine
mi
from
New York, NY
A Study of Neoadjuvant Photodynamic Immunomodulation for Colon Cancer
A Phase I/II Study of Neoadjuvant Photodynamic Immunomodulation for Colon Cancer
Status: Enrolling
Updated: 11/30/2016
Mounst Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-427 When Given to Patients With Advanced and Refractory Solid Tumors or Lymphoma
A Phase I Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral CUDC-427, an Antagonist of Inhibitors of Apoptosis (IAP) Proteins, When Administered in Subjects With Advanced and Refractory Solid Tumors or Lymphoma
Status: Enrolling
Updated:  11/30/2016
Sarah Cannon Research Institute
mi
from
Nashville, TN
Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-427 When Given to Patients With Advanced and Refractory Solid Tumors or Lymphoma
A Phase I Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral CUDC-427, an Antagonist of Inhibitors of Apoptosis (IAP) Proteins, When Administered in Subjects With Advanced and Refractory Solid Tumors or Lymphoma
Status: Enrolling
Updated: 11/30/2016
Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-427 When Given to Patients With Advanced and Refractory Solid Tumors or Lymphoma
A Phase I Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral CUDC-427, an Antagonist of Inhibitors of Apoptosis (IAP) Proteins, When Administered in Subjects With Advanced and Refractory Solid Tumors or Lymphoma
Status: Enrolling
Updated:  11/30/2016
Southern Texas Accelerated Research Therapeutics
mi
from
San Antonio, TX
Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-427 When Given to Patients With Advanced and Refractory Solid Tumors or Lymphoma
A Phase I Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral CUDC-427, an Antagonist of Inhibitors of Apoptosis (IAP) Proteins, When Administered in Subjects With Advanced and Refractory Solid Tumors or Lymphoma
Status: Enrolling
Updated: 11/30/2016
Southern Texas Accelerated Research Therapeutics
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of the Combination of Acalabrutinib (ACP-196) and Pembrolizumab in Advanced Head and Neck Squamous Cell Carcinoma
A Phase 2 Proof-of-Concept Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Advanced Head and Neck Squamous Cell Carcinoma
Status: Enrolling
Updated:  11/30/2016
Oregon Health and Science University
mi
from
Portland, OR
Study of the Combination of Acalabrutinib (ACP-196) and Pembrolizumab in Advanced Head and Neck Squamous Cell Carcinoma
A Phase 2 Proof-of-Concept Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Advanced Head and Neck Squamous Cell Carcinoma
Status: Enrolling
Updated: 11/30/2016
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Acalabrutinib (ACP-196) Alone and in Combination With Pembrolizumab in Ovarian Cancer (KEYNOTE191)
A Phase 2 Proof-of-Concept Study of ACP-196 Alone and in Combination With Pembrolizumab in Subjects With Recurrent Ovarian Cancer
Status: Enrolling
Updated:  11/30/2016
Arizona Gynecology Oncology
mi
from
Tucson, AZ
Acalabrutinib (ACP-196) Alone and in Combination With Pembrolizumab in Ovarian Cancer (KEYNOTE191)
A Phase 2 Proof-of-Concept Study of ACP-196 Alone and in Combination With Pembrolizumab in Subjects With Recurrent Ovarian Cancer
Status: Enrolling
Updated: 11/30/2016
Arizona Gynecology Oncology
mi
from
Tucson, AZ
Click here to add this to my saved trials
Acalabrutinib (ACP-196) Alone and in Combination With Pembrolizumab in Ovarian Cancer (KEYNOTE191)
A Phase 2 Proof-of-Concept Study of ACP-196 Alone and in Combination With Pembrolizumab in Subjects With Recurrent Ovarian Cancer
Status: Enrolling
Updated:  11/30/2016
Jordan Center For Gynecologic Cancer At Penn
mi
from
Philadelphia, PA
Acalabrutinib (ACP-196) Alone and in Combination With Pembrolizumab in Ovarian Cancer (KEYNOTE191)
A Phase 2 Proof-of-Concept Study of ACP-196 Alone and in Combination With Pembrolizumab in Subjects With Recurrent Ovarian Cancer
Status: Enrolling
Updated: 11/30/2016
Jordan Center For Gynecologic Cancer At Penn
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
McFarland Clinic, PC
mi
from
Ames, IA
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
McFarland Clinic, PC
mi
from
Ames, IA
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Mercy Capitol Hospital
mi
from
Des Moines, IA
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Mercy Capitol Hospital
mi
from
Des Moines, IA
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
John Stoddard Cancer Center at Iowa Methodist Medical Center
mi
from
Des Moines, IA
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
John Stoddard Cancer Center at Iowa Methodist Medical Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Medical Oncology and Hematology Associates at John Stoddard Cancer Center
mi
from
Des Moines, IA
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Medical Oncology and Hematology Associates at John Stoddard Cancer Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Medical Oncology and Hematology Associates at Mercy Cancer Center
mi
from
Des Moines, IA
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Medical Oncology and Hematology Associates at Mercy Cancer Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Mercy Cancer Center at Mercy Medical Center - Des Moines
mi
from
Des Moines, IA
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Mercy Cancer Center at Mercy Medical Center - Des Moines
mi
from
Des Moines, IA
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
John Stoddard Cancer Center at Iowa Lutheran Hospital
mi
from
Des Moines, IA
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
John Stoddard Cancer Center at Iowa Lutheran Hospital
mi
from
Des Moines, IA
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Siouxland Hematology-Oncology Associates, LLP
mi
from
Sioux City, IA
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Siouxland Hematology-Oncology Associates, LLP
mi
from
Sioux City, IA
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
St. Luke's Regional Medical Center
mi
from
Sioux City, IA
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
St. Luke's Regional Medical Center
mi
from
Sioux City, IA
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Hickman Cancer Center at Bixby Medical Center
mi
from
Adrian, MI
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Hickman Cancer Center at Bixby Medical Center
mi
from
Adrian, MI
Click here to add this to my saved trials